MLchartDataset catalogue

immunoadjuvant QS-DG

Term · Oncology and biomedicine · MLC-T-ONC-014383

A synthetic saponin, chemically identical to the natural saponin QS-21, with immunoadjuvant activity. When co-administered with vaccine antigens, immunoadjuvant QS-DG may increase total antitumoral vaccine-specific antibody responses and cytotoxic T-lymphocyte (CTL) responses.

Table 1. Record
IdentifierMLC-T-ONC-014383
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON 
{
  "id": "MLC-T-ONC-014383",
  "term": "immunoadjuvant QS-DG",
  "field": "Oncology and biomedicine",
  "definition": "A synthetic saponin, chemically identical to the natural saponin QS-21, with immunoadjuvant activity. When co-administered with vaccine antigens, immunoadjuvant QS-DG may increase total antitumoral vaccine-specific antibody responses and cytotoxic T-lymphocyte (CTL) responses.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/immunoadjuvant-qs-dg/"
}

Record 9,084 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.